134 related articles for article (PubMed ID: 10344732)
1. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.
Knudsen KE; Cavenee WK; Arden KC
Cancer Res; 1999 May; 59(10):2297-301. PubMed ID: 10344732
[TBL] [Abstract][Full Text] [Related]
2. Specificity of cyclin D1 for androgen receptor regulation.
Petre-Draviam CE; Cook SL; Burd CJ; Marshall TW; Wetherill YB; Knudsen KE
Cancer Res; 2003 Aug; 63(16):4903-13. PubMed ID: 12941814
[TBL] [Abstract][Full Text] [Related]
3. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
Xu Y; Chen SY; Ross KN; Balk SP
Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
[TBL] [Abstract][Full Text] [Related]
4. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
5. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
6. ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells.
Kikuchi H; Uchida C; Hattori T; Isobe T; Hiramatsu Y; Kitagawa K; Oda T; Konno H; Kitagawa M
Carcinogenesis; 2007 Aug; 28(8):1752-8. PubMed ID: 17510080
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
Zaidman BZ; Wasser SP; Nevo E; Mahajna J
Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.
Russell A; Thompson MA; Hendley J; Trute L; Armes J; Germain D
Oncogene; 1999 Mar; 18(11):1983-91. PubMed ID: 10208420
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
10. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.
Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H
Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
Minamiguchi K; Kawada M; Ohba S; Takamoto K; Ishizuka M
Mol Cell Endocrinol; 2004 Feb; 214(1-2):175-87. PubMed ID: 15062556
[TBL] [Abstract][Full Text] [Related]
12. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D3 action in androgen receptor regulation and prostate cancer.
Olshavsky NA; Groh EM; Comstock CE; Morey LM; Wang Y; Revelo MP; Burd C; Meller J; Knudsen KE
Oncogene; 2008 May; 27(22):3111-21. PubMed ID: 18084330
[TBL] [Abstract][Full Text] [Related]
14. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
[TBL] [Abstract][Full Text] [Related]
15. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
16. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
17. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
18. Accelerated growth of hepatocytes in association with Up-regulation of cyclin E in transgenic mice expressing the dominant negative form of retinoic acid receptor.
Tsutusmi A; Shiota G; Yamazaki H; Kunisada T; Terada T; Kawasaki H
Biochem Biophys Res Commun; 2000 Nov; 278(1):229-35. PubMed ID: 11071877
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
